• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鉴别肌钙蛋白升高疾病中 1 型心肌梗死的潜在生物标志物。

Potential Biomarkers to Distinguish Type 1 Myocardial Infarction in Troponin-Elevated Diseases.

机构信息

Department of Senior Healthcare, Graduate School, Eulji University, Uijeongbu 11759, Republic of Korea.

Department of Internal Medicine, School of Medicine, Eulji University, Daejeon 34824, Republic of Korea.

出版信息

Int J Mol Sci. 2023 Apr 30;24(9):8097. doi: 10.3390/ijms24098097.

DOI:10.3390/ijms24098097
PMID:37175804
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10179038/
Abstract

Classifying myocardial infarction by subtype is crucial for appropriate patient management. Although troponin is currently the most commonly used biomarker, it is not a specific marker for myocardial infarction and cannot distinguish subtypes. Furthermore, previous studies have confirmed that proteins known as myocardial infarction markers could function to distinguish the type of myocardial infarction. Therefore, we identify a marker that can distinguish type 1 myocardial infarction from other diseases with elevated troponin. We used mass spectrometry to compare type 1 myocardial infarction with other conditions characterized by troponin elevation and identified new candidate markers for disease classification. We then verified these markers, along with those already known to be associated with cardiovascular disease and plaque rupture. We identified -1 acid glycoprotein 2, corticosteroid-binding globulin, and serotransferrin as potential distinguishing markers. The presence of these markers and other parameters, such as chest pain, electrocardiogram, and troponin levels from the complementary diagnostic processes, could provide valuable information to specifically diagnose type 1 myocardial infarction.

摘要

通过亚型对心肌梗死进行分类对于患者的适当管理至关重要。尽管肌钙蛋白目前是最常用的生物标志物,但它并不是心肌梗死的特异性标志物,无法区分亚型。此外,先前的研究已经证实,已知的心肌梗死标志物蛋白可以用于区分心肌梗死的类型。因此,我们确定了一种可以区分 1 型心肌梗死与其他肌钙蛋白升高疾病的标志物。我们使用质谱法比较了 1 型心肌梗死与其他以肌钙蛋白升高为特征的疾病,并确定了用于疾病分类的新候选标志物。然后,我们对这些标志物进行了验证,同时还验证了已经与心血管疾病和斑块破裂相关的标志物。我们确定 -1 酸性糖蛋白 2、皮质醇结合球蛋白和转铁蛋白为潜在的鉴别标志物。这些标志物的存在以及胸痛、心电图和补充诊断过程中的肌钙蛋白水平等其他参数,可能为明确诊断 1 型心肌梗死提供有价值的信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da94/10179038/6c405621369f/ijms-24-08097-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da94/10179038/d2d10926648d/ijms-24-08097-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da94/10179038/f420cad6aae9/ijms-24-08097-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da94/10179038/48d3215a0d49/ijms-24-08097-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da94/10179038/4e18f7395dff/ijms-24-08097-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da94/10179038/6c405621369f/ijms-24-08097-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da94/10179038/d2d10926648d/ijms-24-08097-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da94/10179038/f420cad6aae9/ijms-24-08097-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da94/10179038/48d3215a0d49/ijms-24-08097-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da94/10179038/4e18f7395dff/ijms-24-08097-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da94/10179038/6c405621369f/ijms-24-08097-g005.jpg

相似文献

1
Potential Biomarkers to Distinguish Type 1 Myocardial Infarction in Troponin-Elevated Diseases.鉴别肌钙蛋白升高疾病中 1 型心肌梗死的潜在生物标志物。
Int J Mol Sci. 2023 Apr 30;24(9):8097. doi: 10.3390/ijms24098097.
2
Rapidly rule out acute myocardial infarction by combining copeptin and heart-type fatty acid-binding protein with cardiac troponin.通过联合使用 copeptin、心脏型脂肪酸结合蛋白和心肌肌钙蛋白快速排除急性心肌梗死。
Ann Clin Biochem. 2015 Sep;52(Pt 5):550-61. doi: 10.1177/0004563215578189. Epub 2015 Mar 2.
3
Correlation of plasma copeptin levels and early diagnosis of acute myocardial infarction compared with troponin-T.与肌钙蛋白T相比,血浆 copeptin 水平与急性心肌梗死早期诊断的相关性
J Med Assoc Thai. 2013 Jan;96(1):13-9.
4
Ultra-Sensitive Copeptin and Cardiac Troponin in Diagnosing Non-ST-Segment Elevation Acute Coronary Syndromes--The COPACS Study.超敏 C 肽和心肌肌钙蛋白在诊断非 ST 段抬高型急性冠状动脉综合征中的作用——COPACS 研究。
Am J Med. 2016 Jan;129(1):105-14. doi: 10.1016/j.amjmed.2015.06.033. Epub 2015 Jul 11.
5
[Sensitive troponin: A new definition of acute myocardial infarction?].[敏感肌钙蛋白:急性心肌梗死的新定义?]
Presse Med. 2012 Jun;41(6 Pt 1):634-7. doi: 10.1016/j.lpm.2012.02.036. Epub 2012 Mar 30.
6
A Practical Approach for the Use of High-Sensitivity Cardiac Troponin Assays in the Evaluation of Patients With Chest Pain.高敏心肌肌钙蛋白检测在胸痛患者评估中的实用方法。
Am J Cardiol. 2021 Jan 15;139:1-7. doi: 10.1016/j.amjcard.2020.10.037. Epub 2020 Oct 24.
7
Failure of new biochemical markers to exclude acute myocardial infarction at admission.新的生化标志物在入院时未能排除急性心肌梗死。
Lancet. 1993 Nov 13;342(8881):1220-2. doi: 10.1016/0140-6736(93)92192-v.
8
Chest pain in patients recovering from noncardiac surgery: A retrospective analysis.非心脏手术后患者的胸痛:回顾性分析。
J Clin Anesth. 2022 Nov;82:110932. doi: 10.1016/j.jclinane.2022.110932. Epub 2022 Jul 15.
9
Suspected ACS Patients Presenting With Myocardial Damage or a Type 2 Myocardial Infarction Have a Similar Late Mortality to Patients With a Type 1 Myocardial Infarction: A Report From the Australian and New Zealand 2012 SNAPSHOT ACS Study.疑似急性冠状动脉综合征(ACS)且伴有心肌损伤或2型心肌梗死的患者,其晚期死亡率与1型心肌梗死患者相似:来自2012年澳大利亚和新西兰急性冠状动脉综合征快速评估(SNAPSHOT ACS)研究的报告
Heart Lung Circ. 2017 Oct;26(10):1051-1058. doi: 10.1016/j.hlc.2016.11.018. Epub 2016 Dec 31.
10
Randomised Assessment of Treatment using Panel Assay of Cardiac markers--Contemporary Biomarker Evaluation (RATPAC CBE).随机评估治疗使用面板分析心脏标志物——当代生物标志物评估(RATPAC CBE)。
Health Technol Assess. 2013;17(15):v-vi, 1-122. doi: 10.3310/hta17150.

引用本文的文献

1
Lipidomic and proteomic insights from extracellular vesicles in the postmortem dorsolateral prefrontal cortex reveal substance use disorder-induced brain changes.死后背外侧前额叶皮质细胞外囊泡的脂质组学和蛋白质组学见解揭示了物质使用障碍引起的大脑变化。
Transl Psychiatry. 2025 Aug 15;15(1):284. doi: 10.1038/s41398-025-03512-2.
2
The Latest Advances in Omics Technology for Assessing Tissue Damage: Implications for the Study of Sudden Cardiac Death.用于评估组织损伤的组学技术最新进展:对心脏性猝死研究的启示
Int J Mol Sci. 2025 Jul 16;26(14):6818. doi: 10.3390/ijms26146818.
3
ALK1 Signaling in Human Cardiac Progenitor Cells Promotes a Pro-angiogenic Secretome.

本文引用的文献

1
Clinical and prognostic implications of high-sensitivity cardiac troponin T concentrations in type 2 non-ST elevation myocardial infarction.高敏心肌肌钙蛋白T浓度在2型非ST段抬高型心肌梗死中的临床及预后意义
Int J Cardiol Heart Vasc. 2022 Feb 12;39:100972. doi: 10.1016/j.ijcha.2022.100972. eCollection 2022 Apr.
2
Erythrocyte Fraction in Thrombi Is Increased with Serum Iron by Influencing Fibrin Networks via Oxidative Stress.血栓中的红细胞分馏增加与血清铁有关,通过氧化应激影响纤维蛋白网络。
Oxid Med Cell Longev. 2021 Dec 24;2021:3673313. doi: 10.1155/2021/3673313. eCollection 2021.
3
Risk factors for type 1 and type 2 myocardial infarction.
人类心脏祖细胞中的ALK1信号传导促进促血管生成分泌组。
J Cell Signal. 2024;5(3):122-142. doi: 10.33696/signaling.5.119.
4
From multi-omics approaches to personalized medicine in myocardial infarction.从多组学方法到心肌梗死的个性化医疗
Front Cardiovasc Med. 2023 Oct 30;10:1250340. doi: 10.3389/fcvm.2023.1250340. eCollection 2023.
1 型和 2 型心肌梗死的危险因素。
Eur Heart J. 2022 Jan 13;43(2):127-135. doi: 10.1093/eurheartj/ehab581.
4
A Biomarker Model to Distinguish Types of Myocardial Infarction and Injury.一种用于区分心肌梗死和损伤类型的生物标志物模型。
J Am Coll Cardiol. 2021 Aug 24;78(8):781-790. doi: 10.1016/j.jacc.2021.06.027.
5
Cardiac Troponin Thresholds and Kinetics to Differentiate Myocardial Injury and Myocardial Infarction.心肌肌钙蛋白阈值和动力学鉴别心肌损伤和心肌梗死。
Circulation. 2021 Aug 17;144(7):528-538. doi: 10.1161/CIRCULATIONAHA.121.054302. Epub 2021 Jun 25.
6
Dysregulation of iron metabolism in cardiovascular diseases: From iron deficiency to iron overload.心血管疾病中铁代谢的失调:从缺铁到铁过载。
Biochem Pharmacol. 2021 Aug;190:114661. doi: 10.1016/j.bcp.2021.114661. Epub 2021 Jun 23.
7
Past, Present, and Future of Blood Biomarkers for the Diagnosis of Acute Myocardial Infarction-Promises and Challenges.用于急性心肌梗死诊断的血液生物标志物的过去、现在与未来——前景与挑战
Diagnostics (Basel). 2021 May 15;11(5):881. doi: 10.3390/diagnostics11050881.
8
Cardiovascular Biomarkers in the Early Discrimination of Type 2 Myocardial Infarction.心血管生物标志物在 2 型心肌梗死早期鉴别诊断中的应用。
JAMA Cardiol. 2021 Jul 1;6(7):771-780. doi: 10.1001/jamacardio.2021.0669.
9
High sensitivity troponin, analytical advantages, clinical benefits and clinical challenges - An update.高敏肌钙蛋白:分析优势、临床获益和临床挑战——更新。
Clin Biochem. 2021 May;91:1-8. doi: 10.1016/j.clinbiochem.2021.02.001. Epub 2021 Feb 19.
10
The Role of Complement in Myocardial Infarction Reperfusion Injury: An Underappreciated Therapeutic Target.补体在心肌梗死再灌注损伤中的作用:一个未得到充分重视的治疗靶点。
Front Cell Dev Biol. 2020 Dec 23;8:606407. doi: 10.3389/fcell.2020.606407. eCollection 2020.